Clinical Trial Information Request for Protocol 22-702 Title A Phase 2 Study of Epcoritamab and Rituximab for first-line treatment of follicular lymphoma PI Site Directions: Type your name, contact email and phone number (optional) into the boxes below then click Save to Submit your request for information about this study. Name Email Phone